Rationale And Design Of CURRENT-OASIS 7 Study Published In American Heart Journal
Nov 7th 2008Drug InformationBlood
Sanofi-aventis (NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the American Heart Journal published the rationale and design of the ongoing CURRENT-OASIS 7 trial, a study evaluating the effects of standard and higher-dosing regimens of Plavix® (clopidogrel bisulfate) and aspirin on cardiovascular outcomes and bleeding complications in patients with acute coronary syndrome (ACS) who are intended to undergo intervention with coronary angioplasty.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
